Interferon alfa-2b or not 2b? Significant differences exist in the decision-making process between melanoma patients who accept or decline high-dose adjuvant interferon alfa-2b treatment
Article
Bramlette, Tracy B, Lawson, David H, Washington, Carl V et al. (2007). Interferon alfa-2b or not 2b? Significant differences exist in the decision-making process between melanoma patients who accept or decline high-dose adjuvant interferon alfa-2b treatment
. DERMATOLOGIC SURGERY, 33(1), 11-16. 10.1111/j.1524-4725.2007.33001.x
Bramlette, Tracy B, Lawson, David H, Washington, Carl V et al. (2007). Interferon alfa-2b or not 2b? Significant differences exist in the decision-making process between melanoma patients who accept or decline high-dose adjuvant interferon alfa-2b treatment
. DERMATOLOGIC SURGERY, 33(1), 11-16. 10.1111/j.1524-4725.2007.33001.x